[1]
|
Beierwaltes, W.H., Sturman, M.F., Ryo, U., et al. (1974) Imaging Functional Nodules of the Adrenal Glands with 131-I-19-Iodocholesterol. Journal of Nuclear Medicine, 15, 246-251.
|
[2]
|
李乐乐, 窦京涛. 如何从肾上腺意外瘤中甄选出亚临床库欣综合征[J]. 中国实用内科杂志, 2017, 37(10): 867-870.
https://doi.org/10.19538/j.nk2017100102
|
[3]
|
白求恩精神研究会内分泌和糖尿病学分会《2022年亚临床库欣综合征专家指导建议》编写组. 2022年亚临床库欣综合征专家指导建议[J]. 国际内分泌代谢杂志, 2023, 43(1): 69-76.
https://doi.org/10.3760/cma.j.cn121383-20220930-09061
|
[4]
|
Terzolo, M., Bovio, S., Pia, A., et al. (2007) Sub-clinical Cushing’s Syndrome. Arquivos Brasileiros de Endocrinologia e Metabologia, 51, 1272-1279. https://doi.org/10.1590/S0004-27302007000800013
|
[5]
|
Favero, V., Cremaschi, A., Parazzoli, C., et al. (2022) Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside. International Journal of Molecular Sciences, 23, Article No. 673. https://doi.org/10.3390/ijms23020673
|
[6]
|
赵乃蕊, 袁戈恒, 张俊清. 488例肾上腺意外瘤住院患者临床特征及诊疗[J]. 重庆医科大学学报, 2022, 47(6): 652-656.
|
[7]
|
Jing, Y., Hu, J., Luo, R., et al. (2022) Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population: A Cross-Sectional Study. An-nals of Internal Medicine, 175, 1383-1391. https://doi.org/10.7326/M22-1619
|
[8]
|
Geelhoed, G.W. and Druy, E.M. (1982) Management of the Adrenal “Incidentaloma”. Surgery, 92, 866-874.
|
[9]
|
Ioachimescu, A.G., Remer, E.M. and Hamrahian, A.H. (2015) Adrenal Incidentalomas: A Disease of Modern Technology Offering Opportunities for Im-proved Patient Care. Endocrinology and Metabolism Clinics of North America, 44, 335-354. https://doi.org/10.1016/j.ecl.2015.02.005
|
[10]
|
Zografos, G.N., Perysinakis, I. and Vassilatou, E. (2014) Subclinical Cushing’s Syndrome: Current Concepts and Trends. Hormones (Athens), 13, 323-337. https://doi.org/10.14310/horm.2002.1506
|
[11]
|
Steffensen, C., Bak, A.M., Rubeck, K.Z., et al. (2010) Epidemiolo-gy of Cushing’s Syndrome. Neuroendocrinology, 92, 1-5. https://doi.org/10.1159/000314297
|
[12]
|
杨菁. 亚临床和肾上腺腺瘤型库欣综合征的临床特点和病理生理机制研究[D]: [硕士学位论文]. 杭州: 浙江大学, 2019. https://doi.org/10.27461/d.cnki.gzjdx.2019.001317
|
[13]
|
何新尧, 陈晓, 施秀华, 等. 垂体性库欣病手术疗效分析[J]. 中华神经外科疾病研究杂志, 2013, 12(6): 535-539.
|
[14]
|
Nawata, H., Demura, H., Suda, T. and Takayanagi, R. (1996) Adrenal Preclinical Cushing’s Syndrome. Annual Report of the Ministry of Health and Welfare “Disorder of Ad-renal Hormones” Research Committee, Japan 1995, 223-226. (In Japanese)
|
[15]
|
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., et al. (2011) AME Position Statement on Adrenal Incidentaloma. European Journal of Endocrinology, 164, 851-870. https://doi.org/10.1530/EJE-10-1147
|
[16]
|
Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., et al. (2018) New Diagnostic Criteria of Adrenal Subclinical Cushing’s Syndrome: Opin-ion from the Japan Endocrine Society. Endocrine Journal, 65, 383-393.
https://doi.org/10.1507/endocrj.EJ17-0456
|
[17]
|
Tateishi, Y., Kouyama, R., Mihara, M., Doi, M., Yoshimoto, T., et al. (2012) Evaluation of Salivary Cortisol Measurements for the Diagnosis of Subclinical Cushing’s Syndrome. Endo-crine Journal, 59, 283-289.
https://doi.org/10.1507/endocrj.EJ11-0204
|
[18]
|
Shen, J., Sun, M., Zhou, B. and Yan, J.P. (2014) Nonconformity in the Clinical Practice Guidelines for Subclinical Cushing’s Syndrome: Which Guidelines Are Trustworthy? European Journal of Endocrinology, 171, 421-431.
https://doi.org/10.1530/EJE-14-0345
|
[19]
|
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., et al. (2016) Management of Adrenal Incidentalomas: European Society of Endocrinology Clinical Practice Guideline in Col-laboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 175, G1-G34. https://doi.org/10.1530/EJE-16-0467
|
[20]
|
Rossi, R., Tauchmanova, L., Luciano, A., Di Martino, M., Bat-tista, C., Del Viscovo, L., Nuzzo, V. and Lombardi, G. (2000) Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical Features. The Journal of Clinical Endocrinology & Metabolism, 85, 1440-1448. https://doi.org/10.1210/jcem.85.4.6515
|
[21]
|
Vassilatou, E., Vryonidou, A., Michalopoulou, S., Manolis, J., Carat-zas, J., Phenekos, C. and Tzavara, I. (2009) Hormonal Activity of Adrenal Incidentalomas: Results from a Long-Term Follow-Up Study. Clinical Endocrinology (Oxford), 70, 674-679. https://doi.org/10.1111/j.1365-2265.2008.03492.x
|
[22]
|
Martins, L.C., Conceicao, F.L., Muxfeldt, E.S., et al. (2012) Prevalence and Associated Factors of Subclinical Hypercortisolism in Patients with Resistant Hypertension. Journal of Hypertension, 30, 967-973.
https://doi.org/10.1097/HJH.0b013e3283521484
|
[23]
|
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G. and Angeli, A. (2005) Subclinical Cushing’s Syndrome in Adrenal Incidentalomas. Endocrinology and Me-tabolism Clinics of North America, 34, 423-439.
https://doi.org/10.1016/j.ecl.2005.01.008
|
[24]
|
Reincke, M., Fassnacht, M., Väth, S., Mora, P. and Allolio, B. (1996) Adrenal Incidentalomas: A Manifestation of the Metabolic Syndrome? Endocrine Research, 22, 757-761. https://doi.org/10.1080/07435809609043773
|
[25]
|
Fernández-Real, J.M., Engel, W.R., Simó, R., Salinas, I. and Webb, S.M. (1998) Study of Glucose Tolerance in Consecutive Patients Harbouring Incidental Adrenal Tumours. Study Group of Incidental Adrenal Adenoma. Clinical Endocrinology (Oxford), 49, 53-61. https://doi.org/10.1046/j.1365-2265.1998.00437.x
|
[26]
|
Terzolo, M., Bovio, S., Pia, A., Conton, P.A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., Ambrosi, B. and Mantero, F. (2005) Midnight Serum Cortisol as a Marker of Increased Cardiovascular Risk in Patients with a Clinically in Apparent Adrenal Adenoma. European Journal of Endocrinology, 153, 307-315.
https://doi.org/10.1530/eje.1.01959
|
[27]
|
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.A., Fazio, S. and Lombardi, G. (2002) Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk. The Journal of Clinical Endocrinology & Metabolism, 87, 4872-4878. https://doi.org/10.1210/jc.2001-011766
|
[28]
|
Giordano, R., Marinazzo, E., Berardelli, R., Picu, A., Maccario, M., Ghigo, E. and Arvat, E. (2010) Long-Term Morphological, Hormonal, and Clinical Follow-Up in a Single Unit on 118 Patients with Adrenal Incidentalomas. European Journal of Endocrinology, 162, 779-785. https://doi.org/10.1530/EJE-09-0957
|
[29]
|
Pivonello, R., De Martino, M.C., De Leo, M., Tauchmanovà, L., Fag-giano, A., Lombardi, G. and Colao, A. (2007) Cushing’s Syndrome: Aftermath of the Cure. Arquivos Brasileiros de Endocrinologia e Metabologia, 51, 1381-1391.
https://doi.org/10.1590/S0004-27302007000800025
|
[30]
|
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R. and Stewart, P.M. (2020) Adrenal Incidentaloma. Endocrine Reviews, 41, 775-820. https://doi.org/10.1210/endrev/bnaa008
|
[31]
|
Ceccato, F., Trementino, L., Barbot, M., Antonelli, G., Plebani, M., Denaro, L., Regazzo, D., Rea, F., et al. (2017) Diagnostic Accuracy of Increased Urinary Cortisol/Cortisone Ratio to Differentiate ACTH-Dependent Cushing’s Syndrome. Clinical Endocrinology (Oxford), 87, 500-507. https://doi.org/10.1111/cen.13391
|
[32]
|
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E. and Arvat, E. (2012) Glucose Metabolism in Patients with Subclinical Cushing’s Syndrome. Endocrine, 41, 415-423.
https://doi.org/10.1007/s12020-012-9628-9
|
[33]
|
Di Dalmazi, G., Fanelli, F., Mezzullo, M., Casadio, E., Rinaldi, E., Garelli, S., Giampalma, E., Mosconi, C., Golfieri, R., Vicennati, V., Pagotto, U. and Pasquali, R. (2015) Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism, 100, 3529-3538.
https://doi.org/10.1210/JC.2015-1992
|
[34]
|
Toniato, A., Merante-Boschin, I., Opocher, G., Pelizzo, M.R., Schiavi, F. and Ballotta, E. (2009) Surgical versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Inci-dentalomas: A Prospective Randomized Study. Annals of Surgery, 249, 388-391. https://doi.org/10.1097/SLA.0b013e31819a47d2
|
[35]
|
Morelli, V., Eller-Vainicher, C., Salcuni, A.S., Coletti, F., Iorio, L., Muscogiuri, G., Della Casa, S., Arosio, M., Ambrosi, B., Beck-Peccoz, P. and Chiodini, I. (2011) Risk of New Vertebral Fractures in Patients with Adrenal Incidentaloma with and without Subclinical Hypercortisolism: A Multicenter Longitudinal Study. Journal of Bone and Mineral Research, 26, 1816-1821. https://doi.org/10.1002/jbmr.398
|
[36]
|
Chiodini, I., Vainicher, C.E., Morelli, V., Palmieri, S., Cairoli, E., Salcuni, A.S., Copetti, M. and Scillitani, A. (2016) Mechanisms in Endocrinology: Endogenous Subclinical Hypercortisolism and Bone: A Clinical Review. European Journal of Endocrinology, 175, R265-R282. https://doi.org/10.1530/EJE-16-0289
|
[37]
|
Chiodini, I., Morelli, V., Masserini, B., Salcuni, A.S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., Iorio, L., Beck-Peccoz, P., Arosio, M., Ambrosi, B. and Scillitani, A. (2009) Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 94, 3207-3214. https://doi.org/10.1210/jc.2009-0468
|
[38]
|
Swiatkowska-Stodulska, R., Kaniuka-Jakubowska, S., Wisniewski, P., et al. (2011) The Estimation of Selected Endogenous Anticoagulation Sys-tem Parameters in Patients with Subclinical Cushing’s Syndrome. European Journal of Endocrinology, 165, 865-871. https://doi.org/10.1530/EJE-11-0535
|
[39]
|
Swiatkowska-Stodulska, R., Skibowska-Bielinska, A., Wisniewski, P., et al. (2015) Activity of Selected Coagulation Factors in Overt and Subclinical Hypercortisolism. Endocrine Journal, 62, 687-694.
https://doi.org/10.1507/endocrj.EJ14-0539
|
[40]
|
Swiatkowska-Stodulska, R., Kaniuka-Jakubowska, S., Wisniewski, P., et al. (2012) Homocysteine and alpha-1 Antitrypsin Concentration in Patients with Subclinical Hypercortisolemia. Advances in Medical Sciences, 57, 302-307.
https://doi.org/10.2478/v10039-012-0032-8
|
[41]
|
Rosario Pivonello, A.M.I., De Martino, M.C., Newell-Price, J., Biller, B.M.K. and Colao, A. (2016) Complications of Cushing’s Syndrome: State of the Art. The Lancet Diabetes & Endocrinology, 4, 611-629.
https://doi.org/10.1016/S2213-8587(16)00086-3
|
[42]
|
Lado-Abeal, J., Rodriguez-Arnao, J., Newell-Price, J.D., et al. (1998) Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather than Raised Circulating Androgen Levels. The Journal of Clinical Endocrinology & Metabolism, 83, 3083-3088. https://doi.org/10.1210/jcem.83.9.5084
|
[43]
|
Lause, M., Kamboj, A. and Fernandez Faith, E. (2017) Dermatologic Manifestations of Endocrine Disorders. Translational Pediatrics, 6, 300-312. https://doi.org/10.21037/tp.2017.09.08
|
[44]
|
Luton, J.P., Thieblot, P., Valcke, J.C., et al. (1977) Reversible Gonad-otropin Deficiency in Male Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism, 45, 488-495. https://doi.org/10.1210/jcem-45-3-488
|
[45]
|
Wedrychowicz, A., Hull, B., Tyrawa, K., et al. (2019) Cushing Disease in Children and Adolescents-Assessment of the Clinical Course, Diagnostic Process, and Effects of the Treat-ment-Experience from a Single Paediatric Centre. Pediatric Endocrinology, Diabetes, and Metabolism, 25, 127-143. https://doi.org/10.5114/pedm.2019.87179
|
[46]
|
Palmieri, S., Morelli, V., Salcuni, A.S., et al. (2014) GH Secretion Reserve in Subclinical Hypercortisolism. Pituitary, 17, 470-476. https://doi.org/10.1007/s11102-013-0528-7
|
[47]
|
Fredrickson, D.S., Forsham, P.H. and Thorn, G.W. (1952) The Effect of Massive Cortisone Therapy on Measurements of Thyroid Function. The Journal of Clinical Endocrinology & Metabolism, 12, 541-553.
https://doi.org/10.1210/jcem-12-5-541
|
[48]
|
Terzolo, M., Osella, G., Alì, A., Borretta, G., Cesario, F., Paccotti, P. and Angeli, A. (1998) Subclinical Cushing’s Syndrome in Adrenal Incidentaloma. Clinical Endocrinology (Oxford), 48, 89-97.
https://doi.org/10.1046/j.1365-2265.1998.00357.x
|
[49]
|
Berardelli, R., Karamouzis, I., Marinazzo, E., Prats, E., Picu, A., Giordano, R., Ghigo, E. and Arvat, E. (2010) Effect of Acute and Prolonged Mineralocorticoid Receptor Blockade on Spontaneous and Stimulated Hypothalamic-Pituitary-Adrenal Axis in Humans. European Journal of Endocrinology, 162, 1067-1074. https://doi.org/10.1530/EJE-09-1076
|
[50]
|
Deutschbein, T., Reimondo, G., Di Dalmazi, G., Bancos, I., Patrova, J., Vassiliadi, D.A., Nekić, A.B., et al. (2022) Age-Dependent and Sex-Dependent Disparity in Mortality in Pa-tients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: An International, Retrospective, Cohort Study. The Lancet Diabetes & Endocrinology, 10, 499-508.
https://doi.org/10.1016/S2213-8587(22)00100-0
|
[51]
|
Barzon, L., Fallo, F., Sonino, N. and Boscaro, M. (2002) Development of Overt Cushing’s Syndrome in Patients with Adrenal Incidentaloma. European Journal of Endocrinology, 146, 61-66. https://doi.org/10.1530/eje.0.1460061
|